Boris Schmidt
Impact in
- Physiology top 2%
- Alzheimer's disease research and treatments
- Pharmacology top 1%
- Cholinesterase and Neurodegenerative Diseases
Papers in
-
- Chemical Synthesis and Analysis 15
- Ubiquitin and proteasome pathways 11
- Co-authors
- Marcus Pickhardt (7 shared papers)Eckhard Mandelkow� (6 shared papers)Bernhard Schieffer (5 shared papers)Thomas Krämer (8 shared papers)Fabio Lo Monte (8 shared papers)Eva‐Maria Mandelkow (4 shared papers)Rajeshwar Narlawar (8 shared papers)Jochen Herms (8 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (13 papers)Journal of Medicinal Chemistry (8 papers)ChemMedChem (7 papers)Tetrahedron (4 papers)Neurodegenerative Diseases (4 papers)
- Partner nations
- GermanySwitzerlandBrazil
In The Last Decade
Boris Schmidt
135 papers receiving 4.0k citations
Peers
Comparison fields: 5 of 135
- Physiology 1.0k
- Pharmacology 541
- Neurology 246
- Cellular and Molecular Neuroscience 550
- Organic Chemistry 883
Countries citing papers authored by Boris Schmidt
This map shows the geographic impact of Boris Schmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boris Schmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boris Schmidt more than expected).
Fields of papers citing papers by Boris Schmidt
This network shows the impact of papers produced by Boris Schmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boris Schmidt. The network helps show where Boris Schmidt may publish in the future.
Co-authors
The 25 scholars most cited alongside Boris Schmidt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 139 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 251 | |
| 2 | 2014 | 171 | |
| 3 | 2016 | 155 | |
| 4 | 2007 | 154 | |
| 5 | 2012 | 152 | |
| 6 | 2009 | 146 | |
| 7 | 2002 | 129 | |
| 8 | 2012 | 122 | |
| 9 | 2007 | 109 | |
| 10 | 2003 | 102 | |
| 11 | 2012 | 92 | |
| 12 | 2012 | 84 | |
| 13 | 2005 | 82 | |
| 14 | 2014 | 80 | |
| 15 | 2012 | 77 | |
| 16 | 2010 | 75 | |
| 17 | 1997 | 70 | |
| 18 | 2005 | 67 | |
| 19 | 2006 | 62 | |
| 20 | 2012 | 61 |
About Boris Schmidt
Boris Schmidt is a scholar working on Molecular Biology, Organic Chemistry, Physiology, Oncology and Pharmacology, having authored 139 papers that have together received 4.1k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (29 papers), Computational Drug Discovery Methods (18 papers), Crystal structures of chemical compounds (15 papers), Cholinesterase and Neurodegenerative Diseases (15 papers), Chemical Synthesis and Analysis (15 papers), Ubiquitin and proteasome pathways (11 papers), Peptidase Inhibition and Analysis (10 papers) and Neuroscience and Neuropharmacology Research (9 papers). The work is most often cited by research in Physiology (1.0k citations), Pharmacology (541 citations), Neurology (246 citations), Cellular and Molecular Neuroscience (550 citations) and Organic Chemistry (883 citations). Boris Schmidt has collaborated with scholars based in Germany, Switzerland and Brazil. Frequent co-authors include Marcus Pickhardt, Eckhard Mandelkow�, Bernhard Schieffer, Thomas Krämer, Fabio Lo Monte, Eva‐Maria Mandelkow, Rajeshwar Narlawar, Jochen Herms, Christoph Scholz and Gregor Larbig. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, ChemMedChem, Tetrahedron and Neurodegenerative Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.